Connor, Clark & Lunn Investment Management Ltd. Cytek Biosciences, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 601,695 shares of CTKB stock, worth $2.47 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
601,695
Previous 615,630
2.26%
Holding current value
$2.47 Million
Previous $3.41 Million
14.52%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CTKB
# of Institutions
150Shares Held
72.5MCall Options Held
1KPut Options Held
0-
Black Rock Inc. New York, NY17.1MShares$70 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$48 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD8.25MShares$33.8 Million1.27% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E96.66MShares$27.3 Million1.65% of portfolio
-
State Street Corp Boston, MA4.51MShares$18.5 Million0.0% of portfolio
About Cytek Biosciences, Inc.
- Ticker CTKB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 134,627,008
- Market Cap $552M
- Description
- Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...